TotalMarketCap

Abivax

ABVXNasdaq FranceHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$7.351 B

$84.25 -5.86%

Close of 6 Nov 2026

As of 6 Nov 2026, Abivax (ABVX) has a market capitalization of $7.35B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

78,536,412

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #39CytokineticsCYTK$7.74B
  2. #40AlkermesALKS$7.50B
  3. #41AbivaxABVX$7.35B
  4. #42Praxis Precision MedicinesPRAX$7.34B
  5. #43Rhythm PharmaceuticalsRYTM$7.21B

What if Abivax were worth as much as…

Open the what-if tool →

Gold $28.2T

$323,617.71

Per share 3,841× higher

Bitcoin $1.53T

$17,510.39

Per share 208× higher

Apple $5.02T

$57,484.98

Per share 682× higher

Or at a round number

$10.0B$20.0B$50.0B$100.0B

Where these numbers come from

Share counts and financials for Abivax are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.